| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tango Therapeutics, Inc. | Director | Common Stock | 6.25K | $45K | $7.21 | Jun 5, 2024 | Direct |
| Tango Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 37.5K | Jun 5, 2024 | Direct | ||
| Aligos Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 10.9K | Sep 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | Sep 4, 2024 | 1 | $0 | 4 | Sep 6, 2024 | Chief Financial Officer |
| TNGX | Tango Therapeutics, Inc. | Jun 5, 2024 | 3 | $36K | 4 | Jun 7, 2024 | Director |
| ALGS | Aligos Therapeutics, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Chief Financial Officer |
| ALGS | Aligos Therapeutics, Inc. | Feb 27, 2024 | 6 | $0 | 4 | Feb 28, 2024 | Chief Financial Officer |
| ALGS | Aligos Therapeutics, Inc. | Sep 8, 2023 | 1 | $0 | 4 | Sep 12, 2023 | Chief Financial Officer |
| TNGX | Tango Therapeutics, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
| ALGS | Aligos Therapeutics, Inc. | Mar 15, 2023 | 1 | $0 | 4 | Mar 17, 2023 | Chief Financial Officer |
| ALGS | Aligos Therapeutics, Inc. | Jul 7, 2022 | 1 | $0 | 4 | Jul 11, 2022 | Chief Financial Officer |
| TNGX | Tango Therapeutics, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
| ALGS | Aligos Therapeutics, Inc. | Feb 4, 2022 | 2 | $0 | 4 | Feb 8, 2022 | Chief Financial Officer |
| TNGX | Tango Therapeutics, Inc. | Aug 10, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Director |